1-(Bromomethyl)-3-(trifluoromethoxy)benzene → 5-[4-(3-Trifluoromethoxy-benzyl)-piperazin-1-yl]-quinazoline-2,4-diamine
반응식
[N:1]1([C:7]2[CH:16]=[CH:15][CH:14]=[C:13]3[C:8]=2[C:9]([NH2:18])=[N:10][C:11]([NH2:17])=[N:12]3)[CH2:6][CH2:5][NH:4][CH2:3][CH2:2]1.[F:19][C:20]([F:31])([F:30])[O:21][C:22]1[CH:23]=[C:24]([CH:27]=[CH:28][CH:29]=1)[CH2:25]Br>>[F:19][C:20]([F:30])([F:31])[O:21][C:22]1[CH:23]=[C:24]([CH:27]=[CH:28][CH:29]=1)[CH2:25][N:4]1[CH2:5][CH2:6][N:1]([C:7]2[CH:16]=[CH:15][CH:14]=[C:13]3[C:8]=2[C:9]([NH2:18])=[N:10][C:11]([NH2:17])=[N:12]3)[CH2:2][CH2:3]1참가 물질
3
실험 절차
Title compound was prepared via Resin Method using 5-piperazin-1-yl-quinazoline-2,4-diamine (50 mg; 0.2 mmol) and 3-(trifluoromethoxy)benzyl bromide (94.4 mg; 0.37 mmol) to obtain 58.9 mg. (70% yield). 1H NMR (400 MHz, DMSO-d6) δ 10.0 (br s, 1H), 8.97 (br s, 1H), 7.72 (m, 2H), 7.50 (m, 2H), 7.28 (m, 1H), 7.29 (m, 4H), 3.64 (s, 2H), 3.04 (d, J=10.4 Hz, 2H), 2.93 (m, 4H), 2.32 (m, 2H). ESIMS+419.8 m/z
후처리
- customto obtain 58.9 mg